Utility of serum TNF-α, infliximab trough level, and antibody titers in inflammatory bowel disease

Volume: 20, Issue: 17, Pages: 5031 - 5031
Published: Jan 1, 2014
Abstract
To assess tumor necrosis factor-α (TNF-α), infliximab (IFX) concentrations, and antibodies against IFX molecules in patients with inflammatory bowel disease (IBD) who develop loss of response, side effects, or allergic reaction during anti TNF-α therapy.Blood samples of 36 patients with response loss, side effects, or hypersensitivity to IFX therapy (Group I) and 31 patients in complete clinical remission (Group II) selected as a control group...
Paper Details
Title
Utility of serum TNF-α, infliximab trough level, and antibody titers in inflammatory bowel disease
Published Date
Jan 1, 2014
Volume
20
Issue
17
Pages
5031 - 5031
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.